Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -83.01M | -90.60M | -94.26M | -99.62M | -105.77M |
| Total Depreciation and Amortization | 7.54M | 8.44M | 8.70M | 8.94M | 8.97M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.69M | 16.35M | 17.23M | 18.51M | 19.57M |
| Change in Net Operating Assets | -3.60M | -2.46M | -4.39M | -4.78M | -7.73M |
| Cash from Operations | -64.39M | -68.26M | -72.71M | -76.95M | -84.95M |
| Capital Expenditure | -246.00K | -618.00K | -755.00K | -913.00K | -844.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.02M | 56.70M | 71.01M | 32.21M | 28.77M |
| Cash from Investing | 33.77M | 56.08M | 70.25M | 31.30M | 27.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 58.62M | 108.88M | 51.02M | 50.67M | 51.24M |
| Repurchase of Common Stock | -476.00K | -476.00K | -476.00K | -476.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -415.00K | -- | -- | -- | -- |
| Cash from Financing | 57.73M | 108.41M | 50.54M | 50.19M | 51.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.12M | 96.22M | 48.08M | 4.54M | -5.79M |